{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:31:01Z","timestamp":1791221461232,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaut.2019.102332","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T16:33:27Z","timestamp":1568046807000},"page":"102332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model"],"prefix":"10.1016","volume":"106","author":[{"given":"Neelakshi R.","family":"Jog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah T.","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latisha D.","family":"Heinlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheal","family":"Towner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Guthridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Axtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Harley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.102332_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.gde.2010.12.006","article-title":"Revealing the genetic basis of multiple sclerosis: are we there yet?","volume":"21","author":"Baranzini","year":"2011","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jaut.2019.102332_bib2","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1172\/JCI58649","article-title":"Multiple sclerosis","volume":"122","author":"Nylander","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2019.102332_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of multiple sclerosis: a comprehensive review","volume":"64","author":"Hollenbach","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102332_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","article-title":"Epstein-barr virus infection and multiple sclerosis: a review","volume":"5","author":"Ascherio","year":"2010","journal-title":"J. Neuroimmune Pharmacol. : Off. J. Soc. NeuroI. Pharmacol."},{"key":"10.1016\/j.jaut.2019.102332_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1073858410381531","article-title":"The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis","volume":"17","author":"Pender","year":"2011","journal-title":"The Neuroscientist : Rev. J. Bring. Neurobiol. Neurol. Psy."},{"key":"10.1016\/j.jaut.2019.102332_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0031-1287656","article-title":"Evidence for viral etiology of multiple sclerosis","volume":"31","author":"Tselis","year":"2011","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jaut.2019.102332_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1352458506071470","article-title":"Correlations between Epstein-Barr virus antibody levels and risk factors for multiple sclerosis in healthy individuals","volume":"13","author":"Nielsen","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jaut.2019.102332_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"C. International Multiple Sclerosis Genetics","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2019.102332_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","article-title":"Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis","volume":"59","author":"Thacker","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2019.102332_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060163","article-title":"Epstein barr virus-associated Hodgkin lymphoma","volume":"10","author":"Carbone","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.jaut.2019.102332_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12250-015-3592-5","article-title":"The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma","volume":"30","author":"Tsang","year":"2015","journal-title":"Virol. Sin."},{"key":"10.1016\/j.jaut.2019.102332_bib12","first-page":"267","volume":"390","author":"Rochford","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jaut.2019.102332_bib13","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1212\/WNL.0b013e31821e552a","article-title":"Common viruses associated with lower pediatric multiple sclerosis risk","volume":"76","author":"Waubant","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.102332_bib14","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","article-title":"Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study","volume":"286","author":"Ascherio","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.jaut.2019.102332_bib15","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","article-title":"Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel","volume":"17","author":"Munger","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jaut.2019.102332_bib16","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/acn3.636","article-title":"Heterogeneity in association of remote herpesvirus infections and pediatric MS","volume":"5","author":"Nourbakhsh","year":"2018","journal-title":"Ann. Clin. Trans. Neurol."},{"key":"10.1016\/j.jaut.2019.102332_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jneuroim.2009.08.004","article-title":"Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis","volume":"215","author":"Sundstrom","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.102332_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","article-title":"Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis","volume":"70","author":"De Jager","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.102332_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0042-6822(90)90027-O","article-title":"Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins","volume":"176","author":"Petti","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.jaut.2019.102332_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4049\/jimmunol.134.1.211","article-title":"Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen","volume":"134","author":"Rhodes","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2019.102332_bib21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI112469","article-title":"Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen","volume":"77","author":"Fox","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2019.102332_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","article-title":"Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry","volume":"11","author":"McClain","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2019.102332_bib23","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/nar\/9.13.2999","article-title":"Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments","volume":"9","author":"Arrand","year":"1981","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2019.102332_bib24","first-page":"299","article-title":"Peptide autoantigenicity of the small nuclear ribonucleoprotein-C","volume":"13","author":"James","year":"1995","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102332_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-3083.1994.tb03413.x","article-title":"Basic-amino-acids predominate in the sequential autoantigenic determinants of the small nuclear 70k ribonucleoprotein","volume":"39","author":"James","year":"1994","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2019.102332_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10425179109008433","article-title":"The DNA sequence of the human cytomegalovirus genome","volume":"2","author":"Bankier","year":"1991","journal-title":"DNA Sequence : J. DNA Sequen. Map."},{"key":"10.1016\/j.jaut.2019.102332_bib27","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1073\/pnas.0306267101","article-title":"Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response","volume":"101","author":"McClain","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2019.102332_bib28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-3083.2002.01141.x","article-title":"Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE","volume":"56","author":"McClain","year":"2002","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2019.102332_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2014.04.005","article-title":"Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1","volume":"272","author":"Ruprecht","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.102332_bib30","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1074\/mcp.M115.051664","article-title":"High-density peptide microarray analysis of IgG autoantibody reactivities in serum and cerebrospinal fluid of multiple sclerosis patients","volume":"15","author":"Hecker","year":"2016","journal-title":"Mol. Cell. Proteom. : MCP"},{"key":"10.1016\/j.jaut.2019.102332_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jneuroim.2016.08.016","article-title":"The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins","volume":"299","author":"Dooley","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2019.102332_bib32","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1177\/1352458511410515","article-title":"Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins","volume":"17","author":"Mechelli","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jaut.2019.102332_bib33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/jaut.1998.0227","article-title":"A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif","volume":"11","author":"Arbuckle","year":"1998","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2019.102332_bib34","first-page":"58","article-title":"Lupus humoral autoimmunity induced in a primate model by short peptide immunization","volume":"46","author":"Arbuckle","year":"1998","journal-title":"J. Investig. Med. : Off. Publ. Am. Federat. Clin. Res."},{"key":"10.1016\/j.jaut.2019.102332_bib35","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI117782","article-title":"Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease","volume":"95","author":"Vaughan","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2019.102332_bib36","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ni835","article-title":"A functional and structural basis for TCR cross-reactivity in multiple sclerosis","volume":"3","author":"Lang","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2019.102332_bib37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0014-5793(86)81502-2","article-title":"Analogous amino acid sequences in myelin proteolipid and viral proteins","volume":"207","author":"Shaw","year":"1986","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jaut.2019.102332_bib38","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181e04096","article-title":"Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases","volume":"74","author":"Selter","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2019.102332_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.696","article-title":"The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis","volume":"7","author":"Madsen","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.jaut.2019.102332_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jaut.2019.102332_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102332_bib42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awm038","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.jaut.2019.102332_bib43","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2019.102332_bib44","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awh486","article-title":"Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis","volume":"128","author":"Cepok","year":"2005","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.jaut.2019.102332_bib45","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI200523661","article-title":"Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis","volume":"115","author":"Cepok","year":"2005","journal-title":"J. Clin. Invest."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119300617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119300617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:22:58Z","timestamp":1760257378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119300617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":45,"alternative-id":["S0896841119300617"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102332","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102332"}}